Latest Resources
24 June 2006
Adenovirus type 5 with HIV gag, pol and nef genes / Chris Hani Baragwanath Hospital
Comments and Concerns on the application made by Prof. Glenda Gray in respect of HIV vaccine clinical trial of genetically modified organism (MRKAd5 HIV-1 gag/pol/nef) Comments and concerns It should be noted that this submission is written in the context of a country that is devastated by HIV-AIDS at every level. That solutions are needed […]
14 June 2006
LibertyLink-Rice / Bayer CropScience
Application Made By Bayer Cropscience Gmbh In Respect Of A Commodity Clearance Application For Event Llrice62 To The National Department Of Agriculture, South Africa African Centre for Biosafety, supported by various organisations, groups, companies, and individuals. Read here.
4 June 2006
Article 18(2)(a): The Trojan Horse of the Biosafety Protocol
Read the article here. By Mariam Mayet African Centre for Biosafety July 2006 The “may contain” labels flood the feed sector. Even transboundary movements which could pass as GM-free under existing legislation for LMO-FFPs are labelled as “may contain”. Grain trade and important ports are leading in this clever move which actually ridicules the Protocol. […]
6 May 2006
South Africa, Bioethanol and GMOs: A Heady Mixture
On the 12th of May 2006 Syngenta South Africa (Pty) Ltd, a subsidiary of Swiss chemical giant Syngenta, notified the public of its intention to seek commodity clearance for its GM maize for the use in the production of ethanol. This is the first GM application for commercial approval in the world for a non-feed, […]
1 March 2006
The status of Genetically Modified (GM) pharmaceutical crop research in South Africa
Genetically modified (GM) pharmaceutical crops are crops which have been genetically engineered / modified to produce pharmaceuticals. These pharmaceuticals can be vaccines, anti-bodies or therapeutic proteins. Pharma-crops (as they are known) are a contested and little-known terrain, with remarkable benefits being claimed for them in South Africa. Other voices ask about the contamination of the […]
28 January 2006
Out of Africa: Mysteries of access and benefit sharing
In late 2005 the Edmunds Institute and the African Centre for Biosafety contacted famed bio-pirate hunter Jay McGowan to investigate incidences of access and benefit sharing in Africa. Despite many constraints on the research, McGowan found a plethora of incidents where transnational corporations had utilised African biodiversity without concluding benefit sharing agreements with the local […]
27 January 2006
Biohazard Map of GM Field Trials in SA
Now that the dust is settling after industry’s aggressive PR hype about the unsubstantiated increase in South Africa’s GM commercial plantings for 2006, we bring to you, based upon empirical data, a short briefing paper on the field trials of GMOs grown in South Africa during 2006, compiled by ACB researcher, Rose Williams. This briefing […]
24 January 2006
Bt-Maize 1507 x 59122 x NK 603 / Dow Agrosciences
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB). OBJECTION TO APPLICATION BY DOW AGROSCIENCES TRIPLE STACKED GM MAIZE, EVENTS, 1507 x NK603 x 59199. Read objection here. OVERVIEW The African Centre for Biosafety (ACB) has to date, lodged objections to the following applications by Dow Agrosciences for commodity import clearance: – GM Maize […]
4 December 2005
Roundup Ready Flex Cotton / Monsanto
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) OBJECTION TO MONSANTO’S APPLICATION FOR GENERAL RELEASE OF GM COTTON RR FLEX African Centre for Biosafety, Dec 2005 Read here. Summary The application is for a general release permit to allow the commercial sale and growing of a new transformation event MON88913, also known as […]
1 October 2005
Bt-Maize MON89034 and MON89597 / Monsanto
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) Objections To The Application Made By Monsanto South Africa For A Permit For A Trial Release Of Mon89034 And Mon89597 African Centre for Biosafety, 01 Oct 2005 OVERVIEW DEVELOPER (MONSANTO) APPLICATION: AVAILABLE INFORMATION The dossier supplied by Monsanto is designated Non Confidential Business Information (Non-CBI). […]